Nippon Shinyaku Co., Ltd.

¥3,340As of Sun 8 Nov 2026, 12:00 UTC
TSE:4516Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (2.87%)
Div yield 3.71%
ROE 11.54%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.34)
PE TTM 7.130
TSR TTM 6.79%
Mkt cap ¥225.1B
ROIC 15.88%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥4,053
21.36%
(41.56%)
Sell 6|6|8|2|4
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
78.88
82.78
90.50
95.01
12.16%
18.91%
33.75%
25.72%
Revenue¥B
14.00
13.89
14.44
14.73
11.18%
9.21%
11.29%
10.87%
Peers (US$1.429B)
Cap (US$)
PE
1.766B
9.215x
1.035B
19.71x
1.428B
13.47x
Capital
TTM
5Y
10Y
Leveragex
0.577
—
—
EBIT/Intx
1.174
0.793
0.864
Own earn%
(67.78)
(3.01)
(6.53)
Sh yield%
11.93
25.65
25.67
Owners
Insiders/Inst%
0.43
56.38
Short interest%
4.07
SBC / revenue%
2.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
22–25
$1 testx
0.0
Incr. ROIC%
−31